Worst RD Stories at Supernus

Quote
This is getting ridiculous.Angry Disenchanted Rep meet Mgr That Didn’t Pay Enough Dues in the Field aka Captain Oblivious. You both sound like idiots. And you both are found at every other company out there. The rest of us don’t care how many XRs they release as long as we have a job. The docs do patronize us but who gives a sh** as long as you can feed your family. Those that can make more elsewhere will, just like every other industry out there. Jeesus.
 






anonymous said:
Pipeline?!?! We are the XR company! We will stick Solutrol and Microtrol in any generic med. shit we don’t even have to do phase 3 clinicals on any products because they were already done 20 plus years ago. We have a huge pipeline!
Click to expand...

This right here is why I don’t like working here. We are a great example of what is wrong with this industry. Don’t believe me? If our XRs are so instrumental why haven’t we even taken a step in another country to market our products? It’s because it’s a false narrative and only here in America with our patent laws could a company do something like this. I don’t have to “support my family” so it’s truly starting to drain on my soul. I also love how our leadership team was involved in the adderal and opioid epidemic in this country and they act like they’re the shit at selling meds. As a woman I just want to tell all the DMs and sales leadership to Suck my dick. I can’t wait till I find a better opportunity. Unfortunately, in my interviews a lot of companies are just not impressed with our me too products and the fact that we have to memorize a presentation makes us look super inexperienced to organizations that don’t do scripted pieces. Have a good weekend! SMD!
 






supernus is looking to change its name to SupernusXR. Seriously. Their is 0 R&D on new molecules. It’s all just adding our delivery tech to existing neuro meds. Nothing new or novel will ever come about here.
 






anonymous said:
supernus is looking to change its name to SupernusXR. Seriously. Their is 0 R&D on new molecules. It’s all just adding our delivery tech to existing neuro meds. Nothing new or novel will ever come about here.
Click to expand...

Tragically you r rite. Molindone which is the active ingredient for SPN810 is available in generic form for $20 per month dosed qd for schizophrenia.

Huperzine A which is the active ingredient for the ep product from Biscayne can be bought OTC off amazon, 120 tablets for $20.

SPN812 will be great if we can show an advantage from a controlled head to head phase 3 study vs Strattera. If we cant show this data it's going to be like selling OXR vs Keppra all over again.
 
























anonymous said:
Google Vascepa, then otc fish oil. We’re not the only ones reinventing the wheel
Click to expand...

I get where you are coming from, we aren't the only company out there doing this, could it be time to think differently though? Don't you think we should strive to be something better than a repackaged generic house? I know we had to start out this way w/ TXR and OXR to get momentum as a new company but is it really smart to stay with this strategy for our future with the current payer landscape? This strategy did work very well for Adderall XR & Intuniv that was a different time though.
 






anonymous said:
I get where you are coming from, we aren't the only company out there doing this, could it be time to think differently though? Don't you think we should strive to be something better than a repackaged generic house? I know we had to start out this way w/ TXR and OXR to get momentum as a new company but is it really smart to stay with this strategy for our future with the current payer landscape? This strategy did work very well for Adderall XR & Intuniv that was a different time though.
Click to expand...

I can’t believe that nobody has thought about this before today. So you are saying that we should develop a new chemical which will be a blockbuster? I’m confident that Jack could use someone like you on the board. Great idea. Should we cancel 810 and 812 and just focus on the new product in your opinion?
 






anonymous said:
I can’t believe that nobody has thought about this before today. So you are saying that we should develop a new chemical which will be a blockbuster? I’m confident that Jack could use someone like you on the board. Great idea. Should we cancel 810 and 812 and just focus on the new product in your opinion?
Click to expand...

Nothing wrong with chewing gum and walking at the same time. Launch 810/812 and look for a Vyvanse like product to acquire. You should be familiar with that strategy you worked at Shire.
 


















anonymous said:
Reduced marketing expenditures. The desperation is strong.
Click to expand...
No, no, you’re not getting it. The company isn’t making less money. WE’RE making less money. They still get the profit from all of the doctors and scripts they took away from us under the excuse of “realignments” Profit is still growing healthy. They can afford the marketing, and I doubt that would make a dent anyway. Not hurting for money. Just the out of date bonus plans make it seems that way
 


















anonymous said:
No, no, you’re not getting it. The company isn’t making less money. WE’RE making less money. They still get the profit from all of the doctors and scripts they took away from us under the excuse of “realignments” Profit is still growing healthy. They can afford the marketing, and I doubt that would make a dent anyway. Not hurting for money. Just the out of date bonus plans make it seems that way
Click to expand...

No kidding, you are exactly correct. So much greed it is really disgusting. Fine take the docs away, but, take care of us financially
 












anonymous said:
SK begins hiring reps in 2 weeks. Base salary will range from 110-130 with a bonus structure goal of 50k for reps. Get ready. I
Click to expand...

Nobody here at supernus not in an RD role would be qualified and I guarantee nobody from Supernus will go to SK. This won’t be by choice. SK will have the pick of the litter from UCB, Lundbeck, and Sunovian. They won’t want some primary care reps that push migraine generics. Sorry to burst whoever’s bubble this is and anyone here who thinks they can just jump to another neuro specialist position because your business card says so. We’re not even close and because of that is why I hate it here so much.
 






anonymous said:
Nobody here at supernus not in an RD role would be qualified and I guarantee nobody from Supernus will go to SK. This won’t be by choice. SK will have the pick of the litter from UCB, Lundbeck, and Sunovian. They won’t want some primary care reps that push migraine generics. Sorry to burst whoever’s bubble this is and anyone here who thinks they can just jump to another neuro specialist position because your business card says so. We’re not even close and because of that is why I hate it here so much.
Click to expand...

I disagree, I'm a rep here at Supernus and SK has already contacted me.
 












Top Bottom
Back
Quote